Business Partner ACIC PharmaceuticalsACIC Fine Chemicals Inc.'s main business activity is the supply of Active Pharmaceutical Ingredients (API) to pharmaceutical companies worldwide, with a focus on North American markets. ACIC currently represents Formosa's generic API in North America market.Austin Chemical CompanyAustin Chemical Company, Inc.is a professional agent to bridge customer needs with supplier capabilities; addressing all environmental, safety, and regulatory compliance requirements. Austin is the representative of Formosa Labs in US and Canada for custom synthesis business.Formosa Laboratories JapanFormosa Laboratories Japan has been responding to the needs of Japanese markets as a Japanese affiliate of Formosa Laboratories Inc. in the field of pharmaceutical, promoting the sale of APIs, intermediates and finished products. Formosa Laboratories Japan is as in-country caretaker of DMF in Japan by providing a variety of important services as well as making new technological information available.TrichemTrichem Inc. main business activity is the supply of Active Pharmaceutical Ingredients (API) to pharmaceutical companies worldwide. Trichem currently represents Formosa's generic API in India market.EirGenix Inc.EirGenix provides clients contract services of high quality and cost effectiveness in biopharmaceutical development, analytical testing, and cGMP manufacturing, spanning from pre-clinical to commercial. EirGenix is the strategic partner in ADC contract services with Formosa.Formosa Pharmaceuticals, Inc.Formosa Pharma is a clinical stage biopharmaceutical company with primary focus in the areas of ophthalmology and oncology. Leading asset APP13007 is derived from its proprietary APNTTM Nanoparticle Formulation Technology which is approved by US FDA. Formosa Pharma is developing ADC biosimilar for HER2+ breast cancer treatment.
